Enliven Therapeutics
Price & Volume
Stats
See moreOpen | $20.21 |
Previous Close | $20.01 |
Day Range | $20.01-$20.74 |
52W Range | $13.30-$30.03 |
Market Cap | $1.1B |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.99 |
News
See moreYahoo Finance • 2 months ago
What's going on in today's pre-market session
Yahoo Finance • 2 months ago
Terns Pharmaceuticals’ SWOT analysis: obesity drug stock poised for pivotal data
Yahoo Finance • 2 months ago
Enliven files automatic mixed securities shelf
Yahoo Finance • 2 months ago
Enliven Therapeutics, Inc Q2 Loss Climbs
About
CEO | Mr. Samuel S. Kintz M.B.A. |
CFO | Mr. Benjamin Hohl |
Address | 6200 Lookout Road, Boulder, CO, United States, 80301 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 63 |
